Soleno Therapeutics (SLNO) Retained Earnings (2016 - 2019)
Historic Retained Earnings for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to -$143.2 million.
- Soleno Therapeutics' Retained Earnings fell 1247.97% to -$143.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$143.2 million, marking a year-over-year decrease of 1247.97%. This contributed to the annual value of -$127.0 million for FY2018, which is 1172.85% down from last year.
- Per Soleno Therapeutics' latest filing, its Retained Earnings stood at -$143.2 million for Q3 2019, which was down 1247.97% from -$144.1 million recorded in Q2 2019.
- Over the past 5 years, Soleno Therapeutics' Retained Earnings peaked at -$80.1 million during Q2 2015, and registered a low of -$144.1 million during Q2 2019.
- Over the past 5 years, Soleno Therapeutics' median Retained Earnings value was -$105.2 million (recorded in 2017), while the average stood at -$108.2 million.
- In the last 5 years, Soleno Therapeutics' Retained Earnings plummeted by 3213.24% in 2015 and then tumbled by 908.29% in 2016.
- Soleno Therapeutics' Retained Earnings (Quarter) stood at -$86.2 million in 2015, then decreased by 13.99% to -$98.3 million in 2016, then dropped by 15.65% to -$113.7 million in 2017, then fell by 11.73% to -$127.0 million in 2018, then fell by 12.71% to -$143.2 million in 2019.
- Its last three reported values are -$143.2 million in Q3 2019, -$144.1 million for Q2 2019, and -$134.1 million during Q1 2019.